You have 2 free searches left this month | for more free features.

Condition

Non-arteritic Anterior Ischemic Optic Neuropathy (1)

Optic Atrophy (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Quark Pharmaceuticals (1)

Collaborator

Intervention

qpi-1007 at various doses (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

NAAION

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy Trial in Israel, United States (QPI-1007 at various doses)

Completed

Optic Atrophy
Non-arteritic Anterior Ischemic Optic Neuropathy

QPI-1007 at various doses

Phoenix, Arizona
+27 more

May 9, 2013